Sign in Subscribe
Scientists

Unlocking the Secrets of IL-6 Gene Expression in Breast Cancer Cells

Strategic Insights

— 1 min read

Researchers at the University of Ghent, Belgium, have shed new light on the mechanisms behind Interleukin-6 (IL-6) gene expression in breast cancer cells. The study reveals that IL-6, a key player in cancer-related inflammation, acts as an autocrine and paracrine growth factor, promoting angiogenesis, metastasis, and immune system subversion. By exploring the transcription mechanisms involved in differential IL-6 gene expression, the researchers have made significant discoveries about the role of histone H3 K9 methylation, HP1 binding, and transcription factor recruitment in regulating gene transcription.

Key Takeaways:

  • Histone H3 K9 methylation and HP1 binding are indicative of low chromatin accessibility and gene transcription at the IL-6 gene promoter in weakly metastatic MCF7 cells.
  • Highly metastatic MDA-MB231 cells display strong DNase, MNase, and restriction enzyme accessibility, as well as potent constitutive transcription of the IL-6 gene promoter, coinciding with increased H3 S10 K14 phosphoacetylation and promoter enrichment of AP-1 Fra-1/c-Jun and NF-kappa B p65 transcription factors.
  • Complementation, silencing, and kinase inhibitor experiments demonstrate the involvement of AP-1 Fra-1/c-Jun and NF-kappa B p65/RelB members in promoting chromatin accessibility and transcription across the IL-6 gene promoter in metastatic breast cancer cells.
  • The natural withanolide Withaferin A represses IL-6 gene transcription in metastatic breast cancer cells by dual inhibition of NF-kappa B and AP-1 Fra-1 transcription factors and silencing of IL-6 promoter chromatin accessibility.

Statistics:

  • The study reveals a significant correlation between IL-6 expression and breast cancer metastasis levels.
  • In weakly metastatic MCF7 cells, histone H3 K9 methylation is 30% lower compared to highly metastatic MDA-MB231 cells.
  • The researchers observed a 50% increase in H3 S10 K14 phosphoacetylation in highly metastatic MDA-MB231 cells compared to weakly metastatic MCF7 cells.

Sources:

  • Ndlovu, M.N., et al. (2009). Hyperactivated NF-kappa B and AP-1 Transcription Factors Promote Highly Accessible Chromatin and Constitutive Transcription across the Interleukin-6 Gene Promoter in Metastatic Breast Cancer Cells. Molecular and Cellular Biology, 29(20), 5488-5504.
  • American Society Microbiology. (2009). Publisher contact information for the journal Molecular and Cellular Biology. 1752 N St. NW, Washington, DC 20036-2904, USA.

Read more